TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $17.00K; Additional Paid in Capital, Common StockUSD $1.16B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-348.00K; Retained Earnings (Accumulated Deficit)USD $-935.46M.
- 2026-03-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $1.12B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-283.00K; Retained Earnings (Accumulated Deficit)USD $-894.91M.
- 2025-12-31: Common Stock, Value, IssuedUSD $13.00K; Additional Paid in Capital, Common StockUSD $1.10B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-289.00K; Retained Earnings (Accumulated Deficit)USD $-854.72M.
- 2025-09-30: Common Stock, Value, IssuedUSD $10.00K; Additional Paid in Capital, Common StockUSD $1.04B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-274.00K; Retained Earnings (Accumulated Deficit)USD $-807.80M.
TONIX PHARMACEUTICALS HOLDING CORP. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Stock Split USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.00K | $1.16B | $-348.00K | $-935.46M | $222.28M | 3 month · $1.05M | 3 month · $2.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $14.00K | $1.12B | $-283.00K | $-894.91M | $227.14M | 3 month · $676.00K | 3 month · $1.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $13.00K | $1.10B | $-289.00K | $-854.72M | $245.15M | (m) | 12 month · $6.02M | (m) | (m) | 12 month · 16.19 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $10.00K | $1.04B | $-274.00K | $-807.80M | $231.14M | (m) | 3 month · $1.92M | (m) | (m) | 9 month · 14.84 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $8.00K | $944.06M | $-270.00K | $-775.79M | $168.00M | 3 month · $487.00K | 3 month · $1.42M | (m) | (m) | 3 month · 19.31 6 month · 14.84 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $7.00K | $928.18M | $-266.00K | $-747.52M | $180.40M | 3 month · $2.18M | 3 month · $882.00K | (m) | (m) | 3 month · 12.15 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $4.00K | $870.50M | $-255.00K | $-730.69M | $139.56M | 12 month · $2.26M | 12 month · $4.78M | 12 month · $26.68M | 12 month · $-9.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $156.00K | $782.89M | $-250.00K | $-708.59M | $74.21M | 3 month · $557.00K | 3 month · $1.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $10.00K | $736.71M | $-243.00K | $-694.37M | $42.10M | 3 month · $1.70M | 3 month · $1.15M | 3 month · $10.83M | 3 month · $-9.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $74.00K | $723.91M | $-240.00K | $-615.60M | $108.14M | (m) | 3 month · $1.69M | 3 month · $15.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $3.00K | $706.41M | $-232.00K | $-600.66M | $105.53M | (m) | 12 month · $9.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $18.00K | $694.37M | $-220.00K | $-573.34M | $120.83M | 3 month · $726.00K | 3 month · $2.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $11.00K | $686.02M | $-212.00K | $-545.36M | $140.46M | 3 month · $36.00K | 3 month · $2.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $64.00K | $682.57M | $-211.00K | $-516.99M | $165.43M | 3 month · $101.00K | 3 month · $2.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $12.00K | $677.38M | $-167.00K | $-470.04M | $207.18M | (m) | 12 month · $10.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $6.66M |
| 2022-09-30 | $53.00K | $667.39M | $-160.00K | $-438.36M | $228.92M | 3 month · $805.00K | 3 month · $2.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $32.00K | $637.77M | $-143.00K | $-409.38M | $228.28M | 3 month · $1.43M | 3 month · $2.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $4.25M |
| 2022-03-31 | $553.00K | $593.76M | $-118.00K | $-386.24M | $207.96M | 3 month · $507.00K | 3 month · $2.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $16.00K | $578.61M | $-92.00K | $-359.82M | $218.72M | (m) | 12 month · $7.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $404.00K | $532.16M | $-81.00K | $-330.27M | $202.22M | (m) | 3 month · $2.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $346.00K | $491.96M | $-71.00K | $-311.74M | $180.49M | (m) | 3 month · $2.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $324.00K | $464.84M | $-63.00K | $-288.19M | $176.92M | (m) | 3 month · $1.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $206.00K | $355.04M | $-62.00K | $-267.53M | $87.65M | (m) | 12 month · $2.88M | 12 month · $451.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $140.00K | $313.00M | $-64.00K | $-250.51M | $62.57M | (m) | 3 month · $912.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $105.00K | $292.06M | $-69.00K | $-238.52M | $53.57M | (m) | 3 month · $733.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $49.00K | $255.60M | $-60.00K | $-224.34M | $31.25M | (m) | 3 month · $360.00K | 3 month · $451.00K | (m) | (m) | (m) | (m) | (m) | 3 month · $1.26M | (m) | (m) |
| 2019-12-31 | $9.00K | $226.52M | $-46.00K | $-217.07M | $9.42M | (m) | 12 month · $1.46M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $2.47M | (m) | (m) |
| 2019-09-30 | $2.00K | $218.26M | $-42.00K | $-208.36M | $9.86M | (m) | 3 month · $362.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $6.00K | $213.38M | $-39.00K | $-200.53M | $12.82M | 3 month · $1.00K | 3 month · $431.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $6.00K | $212.53M | $-39.00K | $-194.69M | $17.81M | (m) | 3 month · $305.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $3.00K | $212.16M | $-41.00K | $-188.45M | $23.66M | (m) | 12 month · $1.63M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $3.27M | (m) | (m) |
| 2018-09-30 | $10.00K | $194.59M | $-29.00K | $-180.86M | $13.71M | 9 month · $45.00K | 3 month · $451.00K 9 month · $1.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $9.00K | $191.25M | $-34.00K | $-175.38M | $15.84M | 1 month · $50.00K 6 month · $45.00K | 3 month · $409.00K 6 month · $808.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $8.00K | $187.91M | $-13.00K | $-169.30M | $18.61M | 3 month · $45.00K | 3 month · $399.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.00K | $186.99M | $-12.00K | $-162.36M | $24.62M | (m) | 12 month · $1.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-10-31 | (m) | (m) | (m) | (m) | (m) | 1 month · $15.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $8.00K | $185.55M | $-10.00K | $-156.87M | $28.68M | (m) | 9 month · $1.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $7.00K | $185.06M | $-9.00K | $-151.08M | $33.97M | 6 month · $280.00K | 6 month · $1.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | (m) | (m) | (m) | (m) | (m) | 1 month · $888.00K 3 month · $280.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $4.00K | $168.28M | $-8.00K | $-146.30M | $21.98M | 3 month · $35.00K | 3 month · $567.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $4.00K | $166.60M | $-7.00K | $-141.24M | $25.36M | 12 month · $280.00K | 12 month · $3.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-10-31 | (m) | (m) | (m) | (m) | (m) | 1 month · $585.00K 6 month · $280.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $29.00K | $160.82M | $11.00K | $-133.76M | $27.11M | 9 month · $149.00K | 9 month · $2.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-07-31 | (m) | (m) | (m) | (m) | (m) | 1 month · $105.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $25.00K | $156.17M | $18.00K | $-126.18M | $30.03M | 1 month · $916.00K 6 month · $149.00K | 6 month · $1.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $19.00K | $143.67M | $26.00K | $-116.37M | $27.34M | (m) | 3 month · $896.00K | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $2.00K | $142.68M | $-17.00K | $-102.40M | $40.26M | (m) | 12 month · $4.39M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $19.00K | $141.65M | $17.00K | $-89.04M | $52.65M | (m) | 9 month · $3.38M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $16.00K | $122.01M | $6.00K | $-75.79M | $46.24M | (m) | 6 month · $2.52M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $16.00K | $120.89M | $5.00K | $-64.03M | $56.89M | (m) | 3 month · $1.35M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $11.00K | $90.42M | $2.00K | $-54.34M | $36.09M | (m) | 12 month · $3.05M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $11.00K | $89.12M | $1.00K | $-45.35M | $43.78M | (m) | 9 month · $2.09M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $10.00K | $80.59M | $4.00K | $-37.94M | $42.66M | (m) | 6 month · $1.20M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $10.00K | $79.80M | $1.00K | (m) | $47.92M | (m) | 3 month · $553.00K | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $6.00K | $33.23M | $-1.00K | $-26.73M | $6.51M | (m) | 12 month · $1.72M | 12 month · $51.00K | (m) | (m) | $0.00 | (m) | (m) | (m) | 12 month · $41.02K | (m) |
| 2013-09-30 | $4.88K | $28.45M | (m) | (m) | $5.44M | (m) | 9 month · $1.28M | 9 month · $30.17K | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $2.20K | $17.97M | (m) | (m) | $-1.96M | (m) | 6 month · $833.89K | 6 month · $24.07K | (m) | (m) | $0.00 | (m) | (m) | (m) | 6 month · $41.02K | (m) |
| 2013-03-31 | $2.16K | $17.20M | (m) | (m) | $-639.74K | (m) | 3 month · $392.32K | 3 month · $10.44K | (m) | (m) | $0.00 | (m) | (m) | (m) | 3 month · $41.02K | (m) |
| 2012-12-31 | $2.00K | $16.80M | $0.00 | (m) | $959.00K | (m) | 12 month · $865.00K | (m) | 12 month · $3.00K | (m) | $0.00 | (m) | (m) | 12 month · $710.00K | 12 month · $41.00M | (m) |
| 2012-09-30 | $34.28K | $12.51M | (m) | (m) | $-674.34K | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | 9 month · $571.33K | (m) | (m) | (m) |
| 2012-06-30 | $34.28K | $12.16M | (m) | (m) | $714.89K | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | 6 month · $228.53K | (m) | (m) | (m) |
| 2012-03-31 | $34.28K | $8.00M | (m) | (m) | $-378.89K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $1.35K | $3.94M | (m) | (m) | $-2.45M | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $5.50K | (m) | (m) | (m) | $-15.04K | (m) | (m) | (m) | (m) | (m) | (m) | $59.50K | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | $-12.71K | (m) | (m) | (m) | (m) | (m) | (m) | $59.50K | (m) | (m) | (m) | (m) |
| 2010-12-31 | $18.04K | $2.73M | (m) | (m) | $-175.00K | (m) | (m) | (m) | (m) | (m) | (m) | $59.50K | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $-537.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | $-545.00K | (m) | 12 month · $72.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | (m) | (m) | $-415.00K | (m) | 7 month · $24.19K 7 month · $24.19K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-06-07 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-06-06 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-05-31 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |